Javascript must be enabled to continue!
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
View through CrossRef
The AP-1 transcription factor c-Jun is a key regulator of hepatocyte proliferation. Mice lacking c-Jun in the liver (
c-jun
Δli*
) display impaired liver regeneration after partial hepatectomy (PH). This phenotype correlates with increased protein levels of the cdk-inhibitor p21 in the liver. We performed PH experiments in several double-knockout mouse models to genetically identify the signaling events regulated by c-Jun. Inactivation of
p53
in
c-jun
Δli*
mice abrogated both hepatocyte cell cycle block and increased p21 protein expression. Consistently, liver regeneration was rescued in
c-jun
Δli*
p21
−/−
double-mutant mice. This indicated that c-Jun controls hepatocyte proliferation by a p53/p21-dependent mechanism. Analyses of
p21
mRNA and protein expression in livers of
c-jun
Δli*
mice after PH revealed that the accumulation of p21 protein is due to a post-transcriptional/post-translational mechanism. We have investigated several candidate pathways implicated in the regulation of p21 expression, and observed increased activity of the stress kinase p38 in regenerating livers of
c-jun
Δli*
mice. Importantly, conditional deletion of
p38
α in livers of
c-jun
Δli*
mice fully restored hepatocyte proliferation and attenuated increased p21 protein levels after PH. These data demonstrate that c-Jun/AP-1 regulates liver regeneration through a novel molecular pathway that involves p53, p21, and the stress kinase p38α.
Cold Spring Harbor Laboratory
Title: c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Description:
The AP-1 transcription factor c-Jun is a key regulator of hepatocyte proliferation.
Mice lacking c-Jun in the liver (
c-jun
Δli*
) display impaired liver regeneration after partial hepatectomy (PH).
This phenotype correlates with increased protein levels of the cdk-inhibitor p21 in the liver.
We performed PH experiments in several double-knockout mouse models to genetically identify the signaling events regulated by c-Jun.
Inactivation of
p53
in
c-jun
Δli*
mice abrogated both hepatocyte cell cycle block and increased p21 protein expression.
Consistently, liver regeneration was rescued in
c-jun
Δli*
p21
−/−
double-mutant mice.
This indicated that c-Jun controls hepatocyte proliferation by a p53/p21-dependent mechanism.
Analyses of
p21
mRNA and protein expression in livers of
c-jun
Δli*
mice after PH revealed that the accumulation of p21 protein is due to a post-transcriptional/post-translational mechanism.
We have investigated several candidate pathways implicated in the regulation of p21 expression, and observed increased activity of the stress kinase p38 in regenerating livers of
c-jun
Δli*
mice.
Importantly, conditional deletion of
p38
α in livers of
c-jun
Δli*
mice fully restored hepatocyte proliferation and attenuated increased p21 protein levels after PH.
These data demonstrate that c-Jun/AP-1 regulates liver regeneration through a novel molecular pathway that involves p53, p21, and the stress kinase p38α.
Related Results
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract 1176: Bypassing the dominant-negative effect of mutant p53 in cancer cells
Abstract
The tumor suppressor p53 is mutated in more than 50% of all cancers. The transcriptional activity of p53 depends on localization to the nucleus and formatio...
Unresponsiveness to CHOP Is Associated with Activation of the p38 MAPK Pathway in Patients with DLBCL
Unresponsiveness to CHOP Is Associated with Activation of the p38 MAPK Pathway in Patients with DLBCL
Abstract
Abstract 2647
We have reported in B-NHL cell lines that the p38 MAPK was constitutively activated and was involved in the regulation of tumor...
Implication de p38 et p53 dans le mécanisme d’action du cetuximab dans le cancer colorectal
Implication de p38 et p53 dans le mécanisme d’action du cetuximab dans le cancer colorectal
Le cetuximab est une thérapie ciblée dirigée contre le récepteur du facteur de croissance épidermique (EGFR) utilisée dans le cancer colorectal (CCR) en combinaison avec des chimio...
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Tracking and Inhibiting Atypical Vascular Inflammation
Tracking and Inhibiting Atypical Vascular Inflammation
Mitogen‐activated protein kinase (MAPK) p38 drives the onset and progression of many clinically challenging diseases. However, three decades of research have failed to yield clinic...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract 599: Id4 acts as a tumor suppressor by inducing apoptosis and senescence in p53-dependent manner
Abstract
The physiological mechanisms that can restore biological activity of mutant p53 is an area of high interest given that mutant p53 expression is observed in ...

